DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration


DIAGNOS also announces that it intends to amend the expiry date of 5,228,668 stock warrants (each a “Warrant”) issued as part of a non-brokered private placement of units initially announced on October 25, 2024, and set to expire on April 25, 2026. The amended expiry date shall be September 25, 2026. All other provisions of the Warrants, such as the Warrants exercise price of $0.40 per common share, shall remain unchanged and fully in effect during the extended exercise period.



Source link

  • Related Posts

    Red Lobster to bring back endless shrimp deal that drove it to bankruptcy

    Red Lobster is on a mission to achieve what its new leader has said will be “the greatest comeback in the history of the restaurant industry.” Read More Source link

    Launch fever hits Florida as visitors flock to NASA’s Artemis II moon launch

    The Artemis II event will be the family’s first time seeing a rocket launch in person. Aaron said they planned to drive into Titusville to find a viewing area that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Italy goalkeeper Gianluigi Donnarumma vows to restore national side after failure to reach World Cup

    Italy goalkeeper Gianluigi Donnarumma vows to restore national side after failure to reach World Cup

    ‘I Don’t Care About That’: Trump Says Iran’s Enriched Uranium Is Not a Concern

    Cameo partners with TikTok to boost popularity

    Cameo partners with TikTok to boost popularity

    Red Lobster to bring back endless shrimp deal that drove it to bankruptcy

    SpaceX confidentially files to go public on stock market, reports say | Technology

    SpaceX confidentially files to go public on stock market, reports say | Technology

    Launch fever hits Florida as visitors flock to NASA’s Artemis II moon launch

    Launch fever hits Florida as visitors flock to NASA’s Artemis II moon launch